In March 2023, Bellis Egészségtár Kft. acquired 100% ownership of Patella Gyógyászati Segédeszköz Kft.
Patella Gyógyászati Segédeszköz Kft. is one of the leading medical supply and device wholesaler on the Hungarian market. It distributes approximately 9,000 products to more than 400 medical supply stores, nearly 800 pharmacies and 200 other retail outlets. It was established in 2022 by the divestment of the wholesale division of Patella-96 Kft. The sellers will continue the GYSE manufacturing and import activities in Patella-96 Ltd., while maintaining a trading relationship with the company.
The goal of Bellis Egészségtár Kft., a subsidiary of Hungaropharma Zrt., is to provide cost-effective services to pharmacies through the efficient supply of high-volume medicinal products, dietary supplements, vitamins, and phytotherapy products. Bellis focuses mainly on competitive sales of over-the-counter (OTC) drugs and products used for prevention and health preservation, supported by stable and efficient distribution logistics. Its product portfolio consists of approximately 7,500 dietary supplements, vitamins, phytotherapy, and other healthcare products, complemented by nearly 2,000 popular medicines.
By acquiring Gyógyászati Segédeszköz Kft., Bellis continues its deliberate strategy of expanding its non-pharmaceutical product portfolio. This acquisition provides significant product expansion, primarily in the field of medical devices, medical aids, orthopedic devices, and home care products. It also establishes Bellis as a dominant player in a new market segment, further enhancing its capabilities to serve a wide range of patients.
Concorde MB Partners acted as the exclusive transaction advisor to Bellis Egészségtár Kft. during the acquisition process.
